glp-1 receptor agonist medication Five Unexpected New Uses for Agonists GLP-1 Receptor Agonists and Other

The American Heart Association, American College of Cardiology, and The Obesity Society endorse lifestyle therapy as first-line treatment for overweight and obesity

While expensive relative to other agents, these classes of drugs are generally cost-effective as second-line treatment, although cost-effectiveness data are limited

More research is underway

The Bottom Line Ozempic, Wegovy, and Mounjaro are new drugs that may be useful for PCOS

Wright AK, Carr MJ, Kontopantelis E, Leelarathna L, Thabit H, Emsley R, et al

Additionally, this study revealed a negative correlation between the degree of methylation of the YAP1 promoter and androgen levels, in a dose-dependent manner (224)